A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. [electronic resource]
Producer: 20060417Description: 1260-9 p. digitalISSN:- 1078-0432
- Acid Phosphatase -- blood
- Aged
- Aged, 80 and over
- Androgens -- physiology
- Antigens -- blood
- Antigens, Neoplasm
- Antigens, Surface -- blood
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Cancer Vaccines -- immunology
- Combined Modality Therapy
- Cross-Over Studies
- Disease-Free Survival
- Docetaxel
- Glutamate Carboxypeptidase II -- blood
- Glycoproteins -- blood
- Humans
- Leukocytes, Mononuclear -- drug effects
- Male
- Middle Aged
- Mucin-1
- Mucins -- blood
- Neoplasm Metastasis
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- drug therapy
- Taxoids -- therapeutic use
- Time Factors
- Treatment Outcome
- Vaccination -- methods
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.